Schedule I: Condensed Financial Information of Registrant - Condensed Statements of Cashflows (Details) - USD ($) $ in Thousands		3 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2020	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net (loss) income		$ (9,284)	$ (36,610)	$ (121,086)	$ (156,559)	$ (106,606)	$ (54,032)
Adjustments to reconcile net loss to net cash used in operating activities
Loss (gain) on remeasurement of private warrant liability					(14,486)	15,389	(2,427)
Loss (gain) on remeasurement of earnout liability					(13,822)	18,519
Interest expense (non-cash)					2,270	2,387	7,488
Change in operating assets and liabilities, net of acquisitions and divestitures
Accrued expenses and other current liabilities		(4,034)	1,005	(8,001)	(6,519)	(15,981)	(15,946)
Net cash used in operating activities		(15,401)	(4,156)	(10,352)	(17,736)	(34,777)	(48,669)
Cash flows from investing activities:
Net cash used in investing activities		(8,077)	(38,404)	(46,444)	(79,678)	(263,433)	(10,671)
Cash flows from financing activities:
Proceeds from recapitalization and PIPE financing							305,133
Distribution to stockholders							(30,000)
Transaction costs - recapitalization						(262)	(5,652)
Capped call transactions						(52,913)
Proceeds from exercises of warrants						126,741
Income tax withholdings paid upon vesting of restricted stock units					(3,108)	(28,877)
Repurchase of stock					(1,813)		(42)
Net cash provided by financing activities		1,721	(155)	8,998	1,227	415,549	259,614
Net change in cash, cash equivalents, and restricted cash					(96,187)	117,339	200,274
Cash, cash equivalents, and restricted cash, beginning of period		$ 324,792	$ 324,792	$ 324,792	324,792	207,453	7,179
Cash, cash equivalents, and restricted cash end of period	$ 207,453				228,605	324,792	$ 207,453
Parent
Cash flows from operating activities:
Net (loss) income	3,731				(156,559)	(106,606)
Adjustments to reconcile net loss to net cash used in operating activities
Equity in net loss of subsidiary	(1,360)				175,905	67,046
Loss (gain) on remeasurement of private warrant liability	(2,427)				(14,486)	15,389
Loss (gain) on remeasurement of earnout liability					(13,822)	18,519
Interest expense (non-cash)					2,225	643
Change in operating assets and liabilities, net of acquisitions and divestitures
Accrued expenses and other current liabilities					(9)	930
Net cash used in operating activities	(56)				(6,746)	(4,079)
Cash flows from investing activities:
Net (investment) return of capital in subsidiary	(269,425)				10,551	(458,697)
Net cash used in investing activities	(269,425)				10,551	(458,697)
Cash flows from financing activities:
Proceeds from recapitalization and PIPE financing	305,133
Distribution to stockholders	(30,000)
Transaction costs - recapitalization	(5,652)
Proceeds from debt issuance, net of fees						413,537
Capped call transactions						(52,913)
Proceeds from exercises of warrants						126,741
Proceeds from exercises of stock options					1,116	4,288
Income tax withholdings paid upon vesting of restricted stock units					(3,108)	(28,877)
Repurchase of stock					(1,813)
Net cash provided by financing activities	$ 269,481				$ (3,805)	$ 462,776